JSDT Official Journal 候補論文(原著)
令和5年度 日本透析医学会賞(木本賞)・奨励賞
Official Journal からの候補論文
1.金子 直之,他 透析会誌 55巻 1号(2022 年):11-17
血液透析患者の塩味認識障害の現状と嚥下体操,唾液腺マッサージによる塩味認識障害の改善効果

2.人見 泰正,他 透析会誌 55巻 3号(2022 年):69-76
シャント狭窄部の血管拡張能の違いが治療成績や検査基準に及ぼす影響

3.福田 亜純,他 透析会誌 55巻 5号(2022 年):293-300
腹膜透析選択に関連する因子についての検討

4.菊田 雅宏,他 透析会誌 55巻 9号(2022 年):515-523
血液透析中に発生する微小気泡に関する基礎的検討

5.Toyohiro Hashiba et al. Renal Replacement Therapy 2022 8:5
Aortic arch calcification affects causes of death in patients on hemodialysis: a retrospective cohort study.

6.Takeyuki Hiramatsu et al. Renal Replacement Therapy 2022 8:6
Higher dental care is positively associated with key prognosis factors in peritoneal dialysis patients: findings from a retrospective study.

7.Tomoko Yoshida et al. Renal Replacement Therapy 2022 8:12
Association of inadequate energy intake on admission with activities of daily living at discharge in patients undergoing unplanned hemodialysis initiation: a retrospective case-series study.

8.Ayumi Yoshifuji et al. Renal Replacement Therapy 2022 8:39
Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis.

9.Ryota Yasukawa et al. Renal Replacement Therapy 2022 8:41
Intradialytic parenteral nutrition using a standard amino acid solution not for renal failure in maintenance hemodialysis patients with malnutrition: a multicenter pilot study.

10.Motoyuki Imai et al. Renal Replacement Therapy 2022 8:44
Particulates formed in dialysis fluid: effect of silica in tap water.

11.Kazuyoshi Okada et al. Renal Replacement Therapy 2022 8:52
Effects of high albumin leakage on survival between online hemodiafiltrati

12.Yumi Seto et al. Renal Replacement Therapy 2022 8:57
Long-term body composition changes in patients undergoing hemodialysis: a single-center retrospective study.

13.Kosaku Nitta et al. Renal Replacement Therapy 2022 8:62
Cardiovascular events by different target hemoglobin levels in ESA-hyporespons

14.Kyoko Ito et al. Renal Replacement Therapy 2022 8:64
Effects of ferric citrate hydrate in patients with chronic kidney disease and heart failure: subgroup analysis of a long-term, real-world, post-marketing surveillance study.
